Stephen S. Dominy's most recent trade in Quince Therapeutics Inc was a trade of 125,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 3, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | Stephen S. Dominy | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | Stephen S. Dominy | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Stephen S. Dominy | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |